A targeted functional RNA interference screen uncovers glypican 5 as an entry factor for hepatitis B and D viruses

Clearance of persistent hepatitis C virus infection in humanized mice using a claudin-1-targeting monoclonal antibody

(2015) Laurent Mailly et al.   NATURE BIOTECHNOLOGY

Use of FDA approved therapeutics with hNTCP metabolic inhibitory properties to impair the HDV lifecycle

(2014) Matthieu Blanchet et al.   ANTIVIRAL RESEARCH

Strategies to Inhibit Entry of HBV and HDV Into Hepatocytes

(2014) Stephan Urban et al.   GASTROENTEROLOGY

Binding of hepatitis B virus to its cellular receptor alters the expression profile of genes of bile acid metabolism

(2014) Nicola Oehler et al.   HEPATOLOGY

NTCP and Beyond: Opening the Door to Unveil Hepatitis B Virus Entry

(2014) Koichi Watashi et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Hepatitis B virus infection

(2014) Christian Trépo et al.   LANCET

Loss of hepatitis B surface antigen in a real-life clinical cohort of patients with chronic hepatitis B virus infection

(2014) François Habersetzer et al.   LIVER INTERNATIONAL

Syndecan 4 Is Involved in Mediating HCV Entry through Interaction with Lipoviral Particle-Associated Apolipoprotein E

(2014) Mathieu Lefèvre et al.   PLoS One

Entry of hepatitis B and C viruses — recent progress and future impact

(2014) Thomas F Baumert et al.   Current Opinion in Virology

Evaluation and identification of hepatitis B virus entry inhibitors using HepG2 cells overexpressing a membrane transporter NTCP

(2013) Masashi Iwamoto et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Hepatitis B and D Viruses Exploit Sodium Taurocholate Co-transporting Polypeptide for Species-Specific Entry into Hepatocytes

(2013) Yi Ni et al.   GASTROENTEROLOGY

Cyclosporin A and its analogs inhibit hepatitis B virus entry into cultured hepatocytes through targeting a membrane transporter, sodium taurocholate cotransporting polypeptide (NTCP)

(2013) Koichi Watashi et al.   HEPATOLOGY

Cyclosporin A inhibits hepatitis B and hepatitis D virus entry by cyclophilin-independent interference with the NTCP receptor

(2013) Shirin Nkongolo et al.   JOURNAL OF HEPATOLOGY

Syndecan-1 Serves as the Major Receptor for Attachment of Hepatitis C Virus to the Surfaces of Hepatocytes

(2013) Q. Shi et al.   JOURNAL OF VIROLOGY

Chronic hepatitis D at a standstill: where do we go from here?

(2013) Alessia Ciancio et al.   Nature Reviews Gastroenterology & Hepatology

Proteoglycans Act as Cellular Hepatitis Delta Virus Attachment Receptors

(2013) Oscar Lamas Longarela et al.   PLoS One

The Molecular Virology of Hepatitis B Virus

(2013) Corinna Bremer et al.   SEMINARS IN LIVER DISEASE

A conformational heparan sulfate binding site essential to infectivity overlaps with the conserved hepatitis B virus A-determinant

(2012) Camille Sureau et al.   HEPATOLOGY

The entry inhibitor Myrcludex-B efficiently blocks intrahepatic virus spreading in humanized mice previously infected with hepatitis B virus

(2012) Tassilo Volz et al.   JOURNAL OF HEPATOLOGY

Selection of chronic hepatitis B therapy with high barrier to resistance

(2012) Robert Gish et al.   LANCET INFECTIOUS DISEASES

Virology of Hepatitis D Virus

(2012) John Taylor   SEMINARS IN LIVER DISEASE

Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus

(2012) Huan Yan et al.   eLife

Diverse effects of dimethyl sulfoxide (DMSO) on the differentiation potential of human embryonic stem cells

(2011) Rajarshi Pal et al.   ARCHIVES OF TOXICOLOGY

Glypican-5 stimulates rhabdomyosarcoma cell proliferation by activating Hedgehog signaling

(2011) Fuchuan Li et al.   JOURNAL OF CELL BIOLOGY

Common variation in GPC5 is associated with acquired nephrotic syndrome

(2011) Koji Okamoto et al.   NATURE GENETICS

EGFR and EphA2 are host factors for hepatitis C virus entry and possible targets for antiviral therapy

(2011) Joachim Lupberger et al.   NATURE MEDICINE

Peginterferon plus Adefovir versus Either Drug Alone for Hepatitis Delta

(2011) Heiner Wedemeyer et al.   NEW ENGLAND JOURNAL OF MEDICINE

Glypican-3: A new target for cancer immunotherapy

(2010) Mitchell Ho et al.   EUROPEAN JOURNAL OF CANCER

Genetic variants and risk of lung cancer in never smokers: a genome-wide association study

(2010) Yafei Li et al.   LANCET ONCOLOGY

Glypicans

(2008) Jorge Filmus et al.   GENOME BIOLOGY